Pleural Neoplasms
-
Subject Areas on Research
- 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.
- A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307.
- A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
- A review of chemotherapy trials for malignant mesothelioma.
- Amphiboles and chrysotile asbestos exposure.
- An Investigation of Cancer-Directed Surgery for Different Histologic Subtypes of Malignant Pleural Mesothelioma.
- Antibiotic concentrations in human parapneumonic effusions.
- Asbestos Fiber Concentrations in the Lungs of Brake Repair Workers: An Updated Analysis Using Several Regression Methods to Handle Nondetectable Measurements.
- Asbestos bodies in pulmonary hilar lymph nodes.
- CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma.
- Calcifying fibrous pseudotumor of pleura. A report of three cases of a newly described entity involving the pleura.
- Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).
- Chemotherapy in malignant pleural mesothelioma. A review.
- Comparison of monoclonal versus polyclonal calretinin antibodies for immunohistochemical diagnosis of malignant mesothelioma.
- Crocidolite and mesothelioma.
- Defining best supportive care.
- Delayed-Phase Enhancement for Evaluation of Malignant Pleural Mesothelioma on Computed Tomography: A Prospective Cohort Study.
- Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
- Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B.
- EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.
- Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.
- Effect of erionite on the pleural mesothelium of the Fischer 344 rat.
- Effect of fibrous glass on rat pleural mesothelium. Histopathologic observations.
- Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
- Endoscopic ultrasound-guided fine needle aspiration is useful for nodal staging in patients with pleural mesothelioma.
- Epidemiology of asbestos-related diseases.
- Epithelioid hemangioendothelioma of the pleura: clinical and radiologic features.
- Exposure to brake dust and malignant mesothelioma: a study of 10 cases with mineral fiber analyses.
- Extended surgical staging for potentially resectable malignant pleural mesothelioma.
- Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.
- FDG PET/CT in the management of primary pleural tumors and pleural metastases.
- Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.
- Fiber potency vs. importance.
- From the archives of the AFIP: Localized fibrous tumor of the pleura.
- Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
- Giant thoracic liposarcoma treated with induction chemotherapy followed by surgical resection.
- Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
- Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
- Higher doses of alpha-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma.
- Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.
- Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.
- Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
- Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
- Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.
- Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
- Intrathoracic desmoid tumor: brief report and review of literature.
- Intrathoracic metastasis from an extrathoracic malignancy: a radiographic approach to patient evaluation.
- Invited commentary.
- Invited commentary.
- Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
- Large-scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma.
- Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.
- Localized malignant mesothelioma.
- Lung cancer mortality among asbestos textile workers: a review and update.
- Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers.
- Malignant Mesothelioma and Its Non-Asbestos Causes.
- Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases.
- Malignant mesothelioma in women.
- Malignant mesothelioma not related to asbestos exposure: Analytical scanning electron microscopic analysis of 83 cases and comparison with 442 asbestos-related cases.
- Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
- Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
- Malignant pleural mesothelioma.
- Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
- Mesothelioma vs. adenocarcinoma.
- Mineral fiber content of lung tissue in patients with environmental exposures: household contacts vs. building occupants.
- Mortality among sheet metal workers participating in a respiratory screening program.
- NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
- Non-neoplastic and neoplastic pleural endpoints following fiber exposure.
- Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.
- Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.
- Pathologic quiz case: a 53-year-old man with chest pain and cough. Malignant (diffuse) pleural mesothelioma, biphasic variant, with heterologous differentiation.
- Pathology of human mesothelioma. Etiologic and diagnostic considerations.
- Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report.
- Pleural effusion and renal cell carcinoma: an angiographic-pathologic correlation.
- Pleural malignant mesothelioma following Wilms' tumor.
- Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: a study of 25 cases.
- Quantitative and analytical studies in the diagnosis of mesothelioma.
- Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.
- Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901.
- Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
- Recommendations for the reporting of pleural mesothelioma.
- Recommendations for the reporting of pleural mesothelioma.
- Recommendations for the reporting of pleural mesothelioma.
- Response to letter regarding "Talc and mesothelioma: mineral fiber analysis of 65 cases with clinicopathological correlation".
- Review and update of uncommon primary pleural tumors: a practical approach to diagnosis.
- Role of closed-needle biopsy in the diagnosis of malignant mesothelioma of the pleura.
- Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.
- Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial.
- Silica-induced pleural disease: an unusual case mimicking malignant mesothelioma.
- Strike or Spare? A Review of Lung-Sparing Therapies for Malignant Pleural Mesothelioma.
- Talc and mesothelioma: mineral fiber analysis of 65 cases with clinicopathological correlation.
- Talc pleurodesis simulating pleural metastases on 18F-fluorodeoxyglucose positron emission tomography.
- The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
- The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification.
- The Impact of Adjuvant Hemithoracic Radiation on Outcomes in Patients With Stage I-III Malignant Pleural Mesothelioma: A Dual Registry Analysis.
- The Role of Neoadjuvant Chemotherapy in Patients With Resectable Malignant Pleural Mesothelioma-An Institutional and National Analysis.
- The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.
- The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining.
- The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
- The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
- The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas.
- The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.
- The role of analytical SEM in the determination of causation in malignant mesothelioma.
- The role of imaging in malignant pleural mesothelioma.
- The role of smoking and exposure to asbestos and man-made vitreous fibers in a questionable case of mesothelioma.
- The separation of benign and malignant mesothelial proliferations.
- The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature.
- Twenty-five years of fiber analysis: what have we learned?
- Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
- Well-differentiated papillary mesothelioma.
-
Keywords of People
- Dement, John McCray, Professor Emeritus in Family Medicine and Community Health, Family Medicine & Community Health,Occupational & Environmental Medicine
- Pang, Herbert, Adjunct Assistant Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
- Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology